| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/12/2013 | US20130236508 Method of treatment |
| 09/12/2013 | US20130236497 Treating neoplasms with neurotoxin |
| 09/12/2013 | US20130236496 Use of leukotriene b4 in combination with a toll-like receptor ligand, a rig-i-like receptor ligand, or a nod-like receptor ligand to enhance the innate immune response |
| 09/12/2013 | US20130236473 Therapeutic agents and prophylactic agents for symptoms accompanying autoimmune diseases, inflammatory diseases, allergy diseases and organ transplants |
| 09/12/2013 | US20130236446 Treatment of migraine headache with diffusion of toxin in non-muscle related areas of the mouth |
| 09/12/2013 | US20130236445 Bromelain proteinases (Bromelainases) as chemotherapeutic agents in treating and/or preventing various types of cancer in a mammal |
| 09/12/2013 | US20130236444 Treatment of migraine headache with diffusion of toxin in non-muscle related foraminal sites |
| 09/12/2013 | US20130236441 Methods of treating and preventing thrombotic diseases using ask1 inhibitors |
| 09/12/2013 | US20130236439 Enzyme-activated collagen and tissue matrices |
| 09/12/2013 | US20130236432 Method and device for multiplying and differentiating cells in the presence of growth factors and of a biological matrix or of a supporting structure |
| 09/12/2013 | US20130236431 Compositions and Methods for Tissue Engineering, Tissue Regeneration and Wound Healing |
| 09/12/2013 | US20130236430 Proliferation, separation and transplantation of inhibitory neuron progenitors and proliferation promoting substances for the progenitors |
| 09/12/2013 | US20130236426 Use of decorin for increasing muscle mass |
| 09/12/2013 | US20130236420 Silibinin component for the treatment of hepatitis |
| 09/12/2013 | US20130236418 Immunomodulatory Methods and Systems for Treatment and/or Prevention of Aneurysms |
| 09/12/2013 | US20130236404 Substances and compositions for enhancing dna repair and methods of use |
| 09/12/2013 | DE102012203547A1 Antimikrobielle Peptide Antimicrobial peptides |
| 09/12/2013 | DE102012101911A1 Use of collagen hydrolysate such as food addition agent, as an active ingredient for treating and/or preventing cellulite and stretch marks, preferably stretch marks during pregnancy |
| 09/11/2013 | EP2636684A1 Prevention of infection |
| 09/11/2013 | EP2636680A2 Composition and methods for treatment of congestive heart failure |
| 09/11/2013 | EP2636412A2 Composition for dissolving thrombi, and a pharmaceutical composition for treating stenotic or occlusive vascular diseases which comprises the same |
| 09/11/2013 | EP2636409A1 Combined pharmaceutical composition as antifungal agent |
| 09/11/2013 | EP2635686A2 Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord |
| 09/11/2013 | EP2635682A1 Methods and vectors for cell immortalisation |
| 09/11/2013 | EP2635676A1 Novel endolysin |
| 09/11/2013 | EP2635596A1 Immune-modulating agents and uses therefor |
| 09/11/2013 | EP2635593A1 Vaccines for preventing meningococcal infections |
| 09/11/2013 | EP2635300A1 Dock-and-lock (dnl) constructs for human immunodeficiency virus (hiv) therapy |
| 09/11/2013 | EP2635297A2 A new variant of antihemophilic factor viii having increased specific activity |
| 09/11/2013 | EP2635296A1 Novel composition comprising glucagon |
| 09/11/2013 | EP2635295A1 Control and characterization of memory function |
| 09/11/2013 | EP2635294A1 Immunotherapy against erbb-3 receptor |
| 09/11/2013 | EP2635293A1 Skin wound healing compositions and methods of use thereof |
| 09/11/2013 | EP2635260A2 Compositions and methods for the delivery of therapeutics |
| 09/11/2013 | EP2205257B1 LAG-3Ig (IPM321) dosage regimes for use in the treatment of cancer |
| 09/11/2013 | CN1906296B Methods for the production of apolipoproteins in transgenic plants |
| 09/11/2013 | CN1901934B Use of erythropoietin in the treatment of disturbances of iron distribution in chronic inflammatory intestinal diseases |
| 09/11/2013 | CN103299192A Biomarkers associated with pre-diabetes, diabetes and diabetes related conditions |
| 09/11/2013 | CN103298928A Method for activating helper t cell |
| 09/11/2013 | CN103298827A Cyclic depsipeptides |
| 09/11/2013 | CN103298485A Multivalent vaccine for filariasis |
| 09/11/2013 | CN103298483A A new variant of antihemophilic factor VIII having increased specific activity |
| 09/11/2013 | CN103298482A FVIII peptides for immune tolerance induction and immunodiagnostics |
| 09/11/2013 | CN103298481A Use of prolactin receptor antagonist and chemotherapeutic drug for treating ovarian cancer |
| 09/11/2013 | CN103298480A Control and characterization of memory function |
| 09/11/2013 | CN103298479A Moesin fragments and uses thereof |
| 09/11/2013 | CN103298478A Suppressor for increase in blood gip level, suppressor for increase in blood insulin level, postprandial blood triglyceride level reducing agent, and suppressor for increase in blood glucose level |
| 09/11/2013 | CN103298457A GLP-1 compositions |
| 09/11/2013 | CN103298456A GLP-1 particles and compositions |
| 09/11/2013 | CN103298453A Emulsion method for preparing low residual solvent microparticles |
| 09/11/2013 | CN103298452A Use of PACAP for treating viral infections in aquatic organisms |
| 09/11/2013 | CN103289980A Protease screening methods and proteases indentified thererby |
| 09/11/2013 | CN103289944A Genetic engineering preparation method and application for streptococcus lactis secreting antibacterial peptide |
| 09/11/2013 | CN103288968A An anti-tumor targeting complex and a preparation method and applications thereof |
| 09/11/2013 | CN103288967A Establishment and expression of fusion protein having function of adsorbing heavy metal ions, and application fusion protein in bioremediation |
| 09/11/2013 | CN103288949A Interferon alpha mutant and polyethylene glycol derivative thereof |
| 09/11/2013 | CN103288948A Interferon alpha mutant and polyethylene glycol derivative thereof |
| 09/11/2013 | CN103288947A Interferon alpha mutant and polyethylene glycol derivative thereof |
| 09/11/2013 | CN103288928A Bacillus mojavensis, antifungal lipopeptide compound, and preparation as well as application thereof |
| 09/11/2013 | CN103288926A Tubulin polymerization agent polypeptide and application thereof |
| 09/11/2013 | CN103288922A Tumor necrosis factor (TNF)-alpha polypeptide inhibitor and application thereof |
| 09/11/2013 | CN103288921A Polypeptide inhibitor of vascular endothelial growth factor 2 tyrosine kinase and application thereof |
| 09/11/2013 | CN103288920A Survivin-derived peptide and use thereof |
| 09/11/2013 | CN103288918A Small peptide with dual inhibitory activity against renin and ACE, and applications thereof |
| 09/11/2013 | CN103288673A Platinum ligand and coordination compound thereof |
| 09/11/2013 | CN103285418A Novel biological antibacterial dressing aerosol based on large-area burn wound |
| 09/11/2013 | CN103285402A New application of polyethylene glycol and pigment epithelium derived growth factor conjugate |
| 09/11/2013 | CN103285383A Pharmaceutical composition comprising bromelain and bromelain enteric-coated tablet |
| 09/11/2013 | CN103285382A Application of PTPMeg2 protein in preparation of tumor suppressor products |
| 09/11/2013 | CN103285381A A combination of ribonucleases and cantharidin |
| 09/11/2013 | CN103285380A Novel application of insulin to myocardial preservation |
| 09/11/2013 | CN103285379A Use of GLP-1 (Glucagon-Like Peptide-1) for preparing medicines for preventing and treating macrovascular complications of type 2 diabetes |
| 09/11/2013 | CN103285378A Use of GLP-1 (Glucagon-Like Peptide-1) for preparing medicines for preventing and treating type 2 diabetic cardiomyopathy |
| 09/11/2013 | CN103285377A Target protein for improving spermatogensis |
| 09/11/2013 | CN103285376A Traditional Chinese medicine preparation for treating depression |
| 09/11/2013 | CN103285375A Phycocyanin microsphere preparation and preparation method thereof |
| 09/11/2013 | CN103285374A Amoxicillin colistin sulphate granule and preparation method thereof |
| 09/11/2013 | CN103285373A Preparation method and application of tumor necrosis factor (TNF)-alpha polypeptide inhibitor |
| 09/11/2013 | CN103285372A Cerebroprotein hydrolysate and injection preparation thereof |
| 09/11/2013 | CN103285371A Antibacterial peptide stable preparation and preparation method thereof |
| 09/11/2013 | CN103285281A Pharmaceutical composition containing glutathione peroxidase and preparation method thereof |
| 09/11/2013 | CN103285231A Medicine composition for diabetes adjunctive therapy and preparation method thereof |
| 09/11/2013 | CN103285047A Oudemansiella radicata protein extract and anti-tumor application thereof |
| 09/11/2013 | CN103285046A Auricularia polytricha protein extract and anti-tumor application thereof |
| 09/11/2013 | CN103285045A Pholiota adiposa protein extract and anti-tumor application thereof |
| 09/11/2013 | CN103285043A Method for preparing edible fungus protein extract with antitumor efficacy |
| 09/11/2013 | CN103285042A Black fungus protein extract and anti-tumor application thereof |
| 09/11/2013 | CN103285041A Pycnporus cinnabarnus protein extract and anti-tumor application thereof |
| 09/11/2013 | CN103284928A Medicine for shrinking enlarged pores by utilizing egg white and preparation method thereof |
| 09/11/2013 | CN102823859B Composition comprising medlar, chrysanthemum or honeysuckle and calcium gluconate |
| 09/11/2013 | CN102716469B Dry powder inhalant of interferon alpha |
| 09/11/2013 | CN102657846B Compound traditional Chinese medicine active ingredient preparation used for treating leukemia and production method thereof |
| 09/11/2013 | CN102657845B Applications of odorrana grahami polypeptide AH90 and CW49 for promoting skin regeneration |
| 09/11/2013 | CN102614499B Yak skin collagen compound traditional Tibetan medicine with anti-fatigue effect and preparation process thereof |
| 09/11/2013 | CN102526696B Composition of gastric mucin capsule and preparation method for composition |
| 09/11/2013 | CN102423298B Preparation method of core-shell structure collagen polypeptide chelated calcium nanoparticle |
| 09/11/2013 | CN102416164B Application of interleukin-27 to preparation of medicine for resisting influenza A virus |
| 09/11/2013 | CN102138905B RhBMP-2-loaded chitosan microspheres, preparation method thereof and application thereof |
| 09/11/2013 | CN101838327B Human IL-15 subtype protein and preparation method and application thereof |
| 09/11/2013 | CN101831435B Preparation and application of IL-15 isoform protein of mice |